Med Chem Res (2013) 22:1504–1516
1515
x-ray crystal structure of [ME2SN(PAT)]. Malays J Anal Sci
13(1):63–72
Jin L, Yang P (1997) Synthesis and DNA binding studies of cobalt
(III) mixed-polypyridyl complex. J Inorg Biochem 68:79–83
Kelly JM, Tossi AB, McConnell DJ, OhUigin C (1985) A study of the
interactions of some polypyridyl ruthenium (II) complexes with
DNA using fluorescence spectroscopy, topoisomerisation and
thermal denaturation. Nucleic Acids Res 13:6017–6034
Kumar CV, Barton JK, Turro NJ (1985) Photophysics of Ruthenium
Complexes Bound to Double Helical DNA. J Am Chem Soc
107:5518–5523
Li N, Ma Y, Yang C, Guo L, Yang X (2005) Interaction of anticancer
drug mitoxantrone with DNA analyzed by electrochemical and
spectroscopic methods. Biophys Chem 116:199–205
Li XW, Zheng YJ, Li YT, Wu ZY, Yan CW (2011) Synthesis and
structure of new bicopper(II) complexes bridged by N-(2-
aminopropyl)-N0-(2-oxidophenyl)oxamide: the effects of termi-
nal ligands on structures, anticancer activities and DNA-binding
properties. Eur J Med Chem 46:3851–3857
Affan MA, Foo IPP, Fasihuddin BA, Shamsuddin M (2009b)
Synthesis, characterization and X-ray single crystal studies of
mono-n-butyltin(IV) dichloride complex of pyruvic acid
2- Pyridylhydrazone [n-BuSnCl2(PAP)]. Indian J Chem A
48:1388–1393
Allardyce CS, Dyson PJ (2001) Ruthenium in medicine: current
clinical uses and future prospects. Platin Met Rev 45:62–69
Antolini L, Menabue L, Pellacani GC, Saladin M, Batuglia LP,
Corradi AB, Marcotrigian G (1984) Notes. Magnetic and
spectroscopic properties of dimeric copper(II) complexes of N-
benzyloxycarbonyl-substituted amino acid anions. J Chem Soc
Dalton Trans 2325–2326
Arslantas A, Devrim AK, Necefoglu H (2007) DNA-binding study of
tetraaqua-bis(p-nitrobenzoato)cobalt(II) dihydrate complex:
[Co(H2O)4(p-NO2C6H4COO)2]ꢀ2H2. Int J Mol Sci 8:564–571
Asadi M, Safaei E, Ranjbar B, Hasani L (2004) Thermodynamic and
spectroscopic study on the binding of cationic Zn(II) and Co(II)
tetrapyridinoporphyrazines to calf thymus DNA: the role of the
central metal in binding parameters. New J Chem 28(10):
1227–1234
Lippert B (1999) Cisplatin: chemistry and biochemistry of a leading
anticancer drug. Wiley Interscience, New York
´
Lopez RB, Loeb BL, Boussie T, Meyer TJ (1996) Synthesis of a new
phenanthroline derived ligand with acceptor properties. Tetra-
hedron Lett 37:5437–5440
Bailar JC, Emeleus HJ, Nyholm SR, Dickenson AFT (1975)
Comprehensive inorganic chemistry, vol 3. Pergamon Press,
New York
Bailey AL, Bereman RD, Rillema DP (1986) Redox and spectral
properties of cobalt (11) and copper(I1) tetraazaannulene
complexes: {H2[Me4(RBzo)2[14]tetraeneN4]] (R=H, CO., CH,)
evidence for superoxide ligation and reduction. Inorg Chem
25:3149–3153
Bellamy LJ (1958) The infrared spectra of complex molecules.
Methuen, London, p 353
Betancur-Galvis LA, Saez J, Granados H, Salazar A, Ossa JE (1999)
Antitumor and antiviral activity of Colombian medicinal plant
extracts. Mem Inst Oswaldo Cruz 94:531–535
Mahadvan S, Palaniandavar M (1997) Spectroscopic and voltammet-
ric studies of copper(II) complexes of bis(pyrid-2-yl)-di/trithia
ligands bound to calf thymus DNA. Inorg Chim Acta 254:291–
302
Marchetti F, Pettinari C, Pettinari R, Leonesi D, Lorenzotti A (1999)
Group 12 metal complexes of tetradentate N2O2-Schiff-
base ligands incorporating pyrazole synthesis, characterization
reactivity toward S-donors, N-donors, copper and tin acceptors.
Polyhedron 18:3041–3050
Hong M, Yin H-D, Cui J-C (2011) Weakly-bridged dimeric
diorganotin(IV) compounds derived from pyruvic acid hydra-
zone Schiff base ligands: synthesis, characterization and crystal
structures. Solid State Sci 13(3):501–507
Chaires JB (1998) Energetic of drug DNA interactions. Biopolymers
44:201–215
Cotton FA, Wilkinson G (1988) Advanced inorganic chemistry, 5th
edn. Wiley, New York, p 745
Diaz A, Cao R, Garcia A (1994) Characterization and biological
properties of a copper(II) complex with pyruvic acid thiosem-
icarbazone. Monatshefte fiir Chemie 125:823–825
Ferrari MB, Bisceglie F, Pelosia G, Tarasconia P, Albertini R,
Pinelli S (2001) New methyl pyruvate thiosemicarbazones and
their copper and zinc complexes: synthesis, characterization,
X-ray structures and biological activity. J Inorg Biochem 87:
137–147
Mosmann T (1983) Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity assays.
J Immunol Methods 65:55–63
Narang KK, Pandey JP, Singh VP (1994) Synthesis, characterization
and physicochemical studies of some copper(II) tetrathiocyanato
dithallate(I) complexes with hydrazides and hydrazones. Poly-
hedron 13:529–538
Pathan AH, Naik GN, Bakale RP, Machakanur SS, Gudasi KB (2012)
Ligational behavior of new mononucleating NOO ethyl pyruvate
Schiff base towards 3d metal(II) ions: an emphasis on antipro-
liferative and photocleavage property. Appl Organomet Chem
26:148–155
Ferrari MB, Bisceglie F, Buschini A, Franzoni S, Pelosi G, Pinelli S,
Tarasconi P (2010) Synthesis, structural characterization and
antiproliferative and toxic bio-activities of copper(II) and
nickel(II) citronellal N4-ethylmorpholine thiosemicarbazonates.
J Inorg Biochem 104:199–206
Geary WJ (1971) The use of conductivity measurements in organic
solvents for the characterisation of coordination compounds.
Coord Chem Rev 7:81–122
Pyle AM, Rehmann JP, Meshoyrer R, Kumar CV, Turro NJ, Barton
JK (1989) Mixed-ligand complexes of ruthenium(11): factors
governing binding to DNA. J Am Chem Soc 111:3051–3058
Rajendiran V, Karthik R, Palaniandavar M, Stoeckli-Evans H,
Periasamy VS, Akbarsha MA, Bangalore SS, Krishnamurthy H
(2007) Mixed-ligand Copper(II)-phenolate complexes: effect of
coligand on enhanced DNA and protein binding, DNA cleavage,
and anticancer activity. Inorg Chem 46:8208–8221
Gust R, Posselt D, Sommer K (2004) Development of cobalt(3,4-
diarylsalen) complexes as tumor therapeutics. J Med Chem
47:5837–5846
Sahni R, Agarwal RS, Kushwaha SS (1982) Novel synthesis and
biological activity study of pyrimido [2,1-b] benzothiazole.
J Indian Chem Soc 7:853–857
Hadjikakou SK, Hadjiliadis N (2009) Antiproliferative and anti-tumor
activity of organotin compounds. Coord Chem Rev 253:235–249
Hartinger CG, Dyson PJ (2009) Bioorganometallic chemistry—from
teaching paradigms to medicinal applications. Chem Soc Rev
38:391–401
Jakupec MA, Galanski M, Arion VB, Hartinger CG, Keppler BK
(2008) Antitumour metal compounds: more than theme and
variations. Dalton Trans 2:183–194
Satyanarayana S, Dabrowiak JC, Chaires JB (1992) Neither D nor L
tris (phenanthroline)ruthenium(II) binds to DNA by classical
intercalation. Biochemistry 31:9319–9324
Sharma CL, Mishra V (1985) Antiferromagnetic super exchange and
spectral studies on dimeric 8-quinolinolato complexes of
copper(II) imides. Can J Chem 63:3027–3030
Strohfeldt K, Tacke M (2008) Bioorganometallic fulvene-derived
titanocene anti-cancer drugs. Chem Soc Rev 37:1174–1187
123